Medlogics to pump $30M into coronary stents

Santa Rosa, Calif. medical developer Medlogics has announced a $30 million fourth-round of funding from UBS AG that will close in the first quarter of 2009. The money will go toward marketing its new bare-metal stent, a device that props open blocked arteries, as well as another product that delivers drugs to prevent future blockage, reports VentureWire.

The company says that this is likely to be its last round of venture funding, as it plans to file for an IPO in 2010. The six-year-old company previously raised $22 million from firms like Essex Woodlands Health Ventures and individual investors in the health industry. Medlogics launches its products in Europe, where they have more traction so far.

Next Story: Oracle scoops up Tacit's intellectual property
Previous Story: B2B media platform company Diva.AG gets funding from Creathor Venture